Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-07-21

Clinical Trial Update: Phase III, Evaluate Noninferiority Between Levobupivacaine and Bupivacaine in Spinal Anesthesia. [Phase 3]

View source ↗

Summary

A Phase III trial comparing levobupivacaine and bupivacaine for spinal anesthesia in spine disorders was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine (Bupivacaine)
  • levobupivacaine (levobupivacaine)

Snippet

Sponsor: Cristália Produtos Químicos Farmacêuticos Ltda. | Conditions: Orthopedic Disorder of Spine | Phase 3 | Status: WITHDRAWN